摘要
〔目的〕通过对经综合性治疗的25例睑板腺癌患者的远期随访,观察其术后的复发率及生存率。〔方法〕对25例睑板腺癌进行临床分期,根据不同分期,进行不同的手术方式及化、放疗,随访5至15年,观察远期疗效。〔结果〕25例中术后复发6例,占24%。5年内死亡3例,占12%,5年存活率88%,其中术后10年存活2例,术后15年存活1例。〔结论〕早期发现,早期诊断,以手术为主,化、放疗为辅的综合性治疗是提高睑板腺癌术后存活率的关键。
urpose〕To investigate the recurrence and survival in 25 cases with meibomain gland carcinoma following comprehensive treatment and long term follow up.〔Methods〕Twenty five cases with meibomain gland carcinoma were clinical staged.According to the variety of stages,we treated them in different ways,including operation,chemotherapy and radiotherapy,all patients were followed up 5 to 15 years.〔Results〕Of the 25 cases,recurreuce in 6(24%) and death caused by carcinoma in 3(12%) were found,5 year survival rat was 88% among them,2 cases were alive 10 years,and 1 was alive 15 years after operation.〔Conclusion〕Early detection and dignosis, surgery adjuvant with chemotherapy or radiotherapy are the key to improve survival rate in meibomain gland carcinoma patients.
关键词
睑板腺癌
治疗
生存率
眼睑肿瘤
meibomain gland carcinoma
treatment
survival rate
